Embold Therapeutics, Inc.

CIK 2109643 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Embold Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jul 24, 2026D/A0002109643-26-000003
Feb 9, 2026D0002109643-26-000002
Feb 9, 2026D0002109643-26-000001